Is it safe for a patient with glaucoma to take Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP1 RAs), such as liraglutide (Victoza), semaglutide (Ozempic), or dulaglutide (Trulicity)?
The search strategy employed the following terms: (Incretin Mimetics OR GLP-1 receptor agonists) AND (pancreatic cancer OR pancreatic adenocarcinoma OR pancreatic effects)
How long does semaglutide nausea last
After 1:1 propensity-score matching, 3857 patients per group were analyzed using Cox proportional hazards models
Developed for treating metabolic disease, they are now being investigated as AUD, CUD, and general SUD treatments
In the pharmaceutical segment, the market represents approximately 2.3% , primarily for clinical nutrition and therapeutic interventions